Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn J Barst

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
Circulation|November 15, 2013
Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart AssociationTherese M Giglia, M Patricia Massicotte, James S Tweddell, et al.
Journal of the American College of Cardiology|December 19, 2006
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centersMarius M Hoeper, Stephen H Lee, Robert Voswinckel, et al.
American Heart Journal|June 1, 2002
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertensionDavid Langleben, Brian W Christman, Robyn J Barst, et al.
Circulation|February 14, 2013
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES studyMarius M Hoeper, Robyn J Barst, Robert C Bourge, et al.
Circulation|June 24, 2004
Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshopJohn H Newman, Barry L Fanburg, Stephen L Archer, et al.
American Heart Journal|August 23, 2006
Temporal trends and drug exposures in pulmonary hypertension: an American experienceAlexander M Walker, David Langleben, James J Korelitz, et al.
American Journal of Respiratory and Critical Care Medicine|December 13, 2005
Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertensionElisabeth D Willers, John H Newman, James E Loyd, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 27, 2015
Long-term safety and efficacy of imatinib in pulmonary arterial hypertensionAdaani E Frost, Robyn J Barst, Marius M Hoeper, et al.
American Journal of Respiratory and Critical Care Medicine|March 18, 2014
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell diseaseElizabeth S Klings, Roberto F Machado, Robyn J Barst, et al.
Plos One|July 3, 2014
Risk factors for death in 632 patients with sickle cell disease in the United States and United KingdomMark T Gladwin, Robyn J Barst, J Simon R Gibbs, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Circulation|November 15, 2013
Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart AssociationTherese M Giglia, M Patricia Massicotte, James S Tweddell, et al.
Journal of the American College of Cardiology|December 19, 2006
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centersMarius M Hoeper, Stephen H Lee, Robert Voswinckel, et al.
American Heart Journal|June 1, 2002
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertensionDavid Langleben, Brian W Christman, Robyn J Barst, et al.
Circulation|February 14, 2013
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES studyMarius M Hoeper, Robyn J Barst, Robert C Bourge, et al.
Circulation|June 24, 2004
Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshopJohn H Newman, Barry L Fanburg, Stephen L Archer, et al.
American Heart Journal|August 23, 2006
Temporal trends and drug exposures in pulmonary hypertension: an American experienceAlexander M Walker, David Langleben, James J Korelitz, et al.
American Journal of Respiratory and Critical Care Medicine|December 13, 2005
Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertensionElisabeth D Willers, John H Newman, James E Loyd, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 27, 2015
Long-term safety and efficacy of imatinib in pulmonary arterial hypertensionAdaani E Frost, Robyn J Barst, Marius M Hoeper, et al.
American Journal of Respiratory and Critical Care Medicine|March 18, 2014
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell diseaseElizabeth S Klings, Roberto F Machado, Robyn J Barst, et al.
Plos One|July 3, 2014
Risk factors for death in 632 patients with sickle cell disease in the United States and United KingdomMark T Gladwin, Robyn J Barst, J Simon R Gibbs, et al.
Pageof 14